Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Amortizatization of Intangibles: 2021-2024

Historic Amortizatization of Intangibles for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $12.4 million.

  • Prime Medicine's Amortizatization of Intangibles rose 4.66% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 31.06%. This contributed to the annual value of $12.4 million for FY2024, which is 3.39% down from last year.
  • Prime Medicine's Amortizatization of Intangibles amounted to $12.4 million in FY2024, which was down 3.39% from $12.8 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Amortizatization of Intangibles ranged from a high of $12.8 million in FY2023 and a low of $4.3 million during FY2021.
  • Its 3-year average for Amortizatization of Intangibles is $11.6 million, with a median of $12.4 million in 2024.
  • Per our database at Business Quant, Prime Medicine's Amortizatization of Intangibles soared by 128.05% in 2022 and then fell by 3.39% in 2024.
  • Prime Medicine's Amortizatization of Intangibles (Yearly) stood at $4.3 million in 2021, then soared by 128.05% to $9.8 million in 2022, then spiked by 30.62% to $12.8 million in 2023, then fell by 3.39% to $12.4 million in 2024.